0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Sickle Cell Disease Treatment - Global Market Insights and Sales Trends 2024
Published Date: November 2023
|
Report Code: QYRE-Auto-30X5811
Home | Market Reports | Health| Health Conditions| Genetic Disorders
Global Sickle Cell Disease Treatment Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Sickle Cell Disease Treatment - Global Market Insights and Sales Trends 2024

Code: QYRE-Auto-30X5811
Report
November 2023
Pages:112
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Sickle Cell Disease Treatment - Market Size

The global Sickle Cell Disease Treatment market size is expected to reach US$ 4132.3 million by 2029, growing at a CAGR of 11.4% from 2023 to 2029.

Sickle Cell Disease Treatment -  Market

Sickle Cell Disease Treatment - Market

Sickle cell disease treatment includes medical interventions and therapies used to manage the symptoms and complications of sickle cell disease, a genetic disorder affecting red blood cells.
The market is mainly driven by the significant applications of Sickle Cell Disease Treatment in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Sickle Cell Disease Treatment market. Sickle Cell Anemia, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Sickle Beta Thalassemia segment is estimated at % CAGR for the next seven-year period.
The market for sickle cell disease treatment is driven by the demand for disease-modifying therapies and the need for improved treatments for pain crises and complications associated with sickle cell disease. The market's growth is also influenced by ongoing research in gene therapy and novel drug candidates for sickle cell disease.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Sickle Cell Disease Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Sickle Cell Disease Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Sickle Cell Disease Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Sickle Cell Disease Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Sickle Cell Disease Treatment covered in this report include AstraZeneca, Eli Lilly, Novartis, Pfizer, Baxter, Emmaus Life Sciences, Bluebird bio, Blood Therapeutics and Sangamo Therapeutics, etc.
The global Sickle Cell Disease Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AstraZeneca
Eli Lilly
Novartis
Pfizer
Baxter
Emmaus Life Sciences
Bluebird bio
Blood Therapeutics
Sangamo Therapeutics
Acceleron Pharma
Arena Pharmaceuticals
Alnylam Pharmaceuticals
Sanofi
CRISPR Therapeutics
Vertex Pharmaceuticals, Inc.

Scope of Sickle Cell Disease Treatment - Market Report

Report Metric Details
Report Name Sickle Cell Disease Treatment - Market
Forecasted market size in 2029 US$ 4132.3 million
CAGR 11.4%
Forecasted years 2023 - 2029
Global Sickle Cell Disease Treatment market, by region:
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Sickle Cell Disease Treatment market, Segment by Type:
  • Sickle Cell Anemia
  • Sickle Beta Thalassemia
  • Sickle Hemoglobin C Disease
Global Sickle Cell Disease Treatment market, by Application
  • Hospitals
  • Clinics
  • Others
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter Four: Detailed analysis of Sickle Cell Disease Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
  • Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
  • Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter Twelve: Research Finding/Conclusion

FAQ for this report

What is the Sickle Cell Disease Treatment - Market size in 2029?

Ans: The Sickle Cell Disease Treatment - Market size in 2029 will be US$ 4132.3 million.

What are the Application segmentation covered in the Sickle Cell Disease Treatment - Market report?

Ans: The Applications covered in the Sickle Cell Disease Treatment - Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Sickle Cell Disease Treatment - Market report?

Ans: The Types covered in the Sickle Cell Disease Treatment - Market report are Sickle Cell Anemia, Sickle Beta Thalassemia, Sickle Hemoglobin C Disease

1 Market Overview of Sickle Cell Disease Treatment
1.1 Sickle Cell Disease Treatment Market Overview
1.1.1 Sickle Cell Disease Treatment Product Scope
1.1.2 Sickle Cell Disease Treatment Market Status and Outlook
1.2 Global Sickle Cell Disease Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Sickle Cell Disease Treatment Market Size by Region (2018-2029)
1.4 Global Sickle Cell Disease Treatment Historic Market Size by Region (2018-2023)
1.5 Global Sickle Cell Disease Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Sickle Cell Disease Treatment Market Size (2018-2029)
1.6.1 North America Sickle Cell Disease Treatment Market Size (2018-2029)
1.6.2 Europe Sickle Cell Disease Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Sickle Cell Disease Treatment Market Size (2018-2029)
1.6.4 Latin America Sickle Cell Disease Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Sickle Cell Disease Treatment Market Size (2018-2029)
2 Sickle Cell Disease Treatment Market by Type
2.1 Introduction
2.1.1 Sickle Cell Anemia
2.1.2 Sickle Beta Thalassemia
2.1.3 Sickle Hemoglobin C Disease
2.2 Global Sickle Cell Disease Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Sickle Cell Disease Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Sickle Cell Disease Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Sickle Cell Disease Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Sickle Cell Disease Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Sickle Cell Disease Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Sickle Cell Disease Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Sickle Cell Disease Treatment Revenue Breakdown by Type (2018-2029)
3 Sickle Cell Disease Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Sickle Cell Disease Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Sickle Cell Disease Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Sickle Cell Disease Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Sickle Cell Disease Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Sickle Cell Disease Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Sickle Cell Disease Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Sickle Cell Disease Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Sickle Cell Disease Treatment Revenue Breakdown by Application (2018-2029)
4 Sickle Cell Disease Treatment Competition Analysis by Players
4.1 Global Sickle Cell Disease Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sickle Cell Disease Treatment as of 2022)
4.3 Date of Key Players Enter into Sickle Cell Disease Treatment Market
4.4 Global Top Players Sickle Cell Disease Treatment Headquarters and Area Served
4.5 Key Players Sickle Cell Disease Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Sickle Cell Disease Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 AstraZeneca
5.1.1 AstraZeneca Profile
5.1.2 AstraZeneca Main Business
5.1.3 AstraZeneca Sickle Cell Disease Treatment Products, Services and Solutions
5.1.4 AstraZeneca Sickle Cell Disease Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 AstraZeneca Recent Developments
5.2 Eli Lilly
5.2.1 Eli Lilly Profile
5.2.2 Eli Lilly Main Business
5.2.3 Eli Lilly Sickle Cell Disease Treatment Products, Services and Solutions
5.2.4 Eli Lilly Sickle Cell Disease Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Eli Lilly Recent Developments
5.3 Novartis
5.3.1 Novartis Profile
5.3.2 Novartis Main Business
5.3.3 Novartis Sickle Cell Disease Treatment Products, Services and Solutions
5.3.4 Novartis Sickle Cell Disease Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 Pfizer Recent Developments
5.4 Pfizer
5.4.1 Pfizer Profile
5.4.2 Pfizer Main Business
5.4.3 Pfizer Sickle Cell Disease Treatment Products, Services and Solutions
5.4.4 Pfizer Sickle Cell Disease Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 Pfizer Recent Developments
5.5 Baxter
5.5.1 Baxter Profile
5.5.2 Baxter Main Business
5.5.3 Baxter Sickle Cell Disease Treatment Products, Services and Solutions
5.5.4 Baxter Sickle Cell Disease Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Baxter Recent Developments
5.6 Emmaus Life Sciences
5.6.1 Emmaus Life Sciences Profile
5.6.2 Emmaus Life Sciences Main Business
5.6.3 Emmaus Life Sciences Sickle Cell Disease Treatment Products, Services and Solutions
5.6.4 Emmaus Life Sciences Sickle Cell Disease Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Emmaus Life Sciences Recent Developments
5.7 Bluebird bio
5.7.1 Bluebird bio Profile
5.7.2 Bluebird bio Main Business
5.7.3 Bluebird bio Sickle Cell Disease Treatment Products, Services and Solutions
5.7.4 Bluebird bio Sickle Cell Disease Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Bluebird bio Recent Developments
5.8 Blood Therapeutics
5.8.1 Blood Therapeutics Profile
5.8.2 Blood Therapeutics Main Business
5.8.3 Blood Therapeutics Sickle Cell Disease Treatment Products, Services and Solutions
5.8.4 Blood Therapeutics Sickle Cell Disease Treatment Revenue (US$ Million) & (2018-2023)
5.8.5 Blood Therapeutics Recent Developments
5.9 Sangamo Therapeutics
5.9.1 Sangamo Therapeutics Profile
5.9.2 Sangamo Therapeutics Main Business
5.9.3 Sangamo Therapeutics Sickle Cell Disease Treatment Products, Services and Solutions
5.9.4 Sangamo Therapeutics Sickle Cell Disease Treatment Revenue (US$ Million) & (2018-2023)
5.9.5 Sangamo Therapeutics Recent Developments
5.10 Acceleron Pharma
5.10.1 Acceleron Pharma Profile
5.10.2 Acceleron Pharma Main Business
5.10.3 Acceleron Pharma Sickle Cell Disease Treatment Products, Services and Solutions
5.10.4 Acceleron Pharma Sickle Cell Disease Treatment Revenue (US$ Million) & (2018-2023)
5.10.5 Acceleron Pharma Recent Developments
5.11 Arena Pharmaceuticals
5.11.1 Arena Pharmaceuticals Profile
5.11.2 Arena Pharmaceuticals Main Business
5.11.3 Arena Pharmaceuticals Sickle Cell Disease Treatment Products, Services and Solutions
5.11.4 Arena Pharmaceuticals Sickle Cell Disease Treatment Revenue (US$ Million) & (2018-2023)
5.11.5 Arena Pharmaceuticals Recent Developments
5.12 Alnylam Pharmaceuticals
5.12.1 Alnylam Pharmaceuticals Profile
5.12.2 Alnylam Pharmaceuticals Main Business
5.12.3 Alnylam Pharmaceuticals Sickle Cell Disease Treatment Products, Services and Solutions
5.12.4 Alnylam Pharmaceuticals Sickle Cell Disease Treatment Revenue (US$ Million) & (2018-2023)
5.12.5 Alnylam Pharmaceuticals Recent Developments
5.13 Sanofi
5.13.1 Sanofi Profile
5.13.2 Sanofi Main Business
5.13.3 Sanofi Sickle Cell Disease Treatment Products, Services and Solutions
5.13.4 Sanofi Sickle Cell Disease Treatment Revenue (US$ Million) & (2018-2023)
5.13.5 Sanofi Recent Developments
5.14 CRISPR Therapeutics
5.14.1 CRISPR Therapeutics Profile
5.14.2 CRISPR Therapeutics Main Business
5.14.3 CRISPR Therapeutics Sickle Cell Disease Treatment Products, Services and Solutions
5.14.4 CRISPR Therapeutics Sickle Cell Disease Treatment Revenue (US$ Million) & (2018-2023)
5.14.5 CRISPR Therapeutics Recent Developments
5.15 Vertex Pharmaceuticals, Inc.
5.15.1 Vertex Pharmaceuticals, Inc. Profile
5.15.2 Vertex Pharmaceuticals, Inc. Main Business
5.15.3 Vertex Pharmaceuticals, Inc. Sickle Cell Disease Treatment Products, Services and Solutions
5.15.4 Vertex Pharmaceuticals, Inc. Sickle Cell Disease Treatment Revenue (US$ Million) & (2018-2023)
5.15.5 Vertex Pharmaceuticals, Inc. Recent Developments
6 North America
6.1 North America Sickle Cell Disease Treatment Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Sickle Cell Disease Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Sickle Cell Disease Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Sickle Cell Disease Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Sickle Cell Disease Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Sickle Cell Disease Treatment Market Dynamics
11.1 Sickle Cell Disease Treatment Industry Trends
11.2 Sickle Cell Disease Treatment Market Drivers
11.3 Sickle Cell Disease Treatment Market Challenges
11.4 Sickle Cell Disease Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables
    Table 1. Global Market Sickle Cell Disease Treatment Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
    Table 2. Global Sickle Cell Disease Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 3. Global Sickle Cell Disease Treatment Market Size Share by Region (2018-2023)
    Table 4. Global Sickle Cell Disease Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 5. Global Sickle Cell Disease Treatment Forecasted Market Size Share by Region (2024-2029)
    Table 6. Global Sickle Cell Disease Treatment Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
    Table 7. Global Sickle Cell Disease Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 8. Global Sickle Cell Disease Treatment Revenue Market Share by Type (2018-2023)
    Table 9. Global Sickle Cell Disease Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 10. Global Sickle Cell Disease Treatment Revenue Market Share by Type (2024-2029)
    Table 11. North America Sickle Cell Disease Treatment Revenue by Type (2018-2023) & (US$ Million)
    Table 12. North America Sickle Cell Disease Treatment Revenue by Type (2024-2029) & (US$ Million)
    Table 13. Europe Sickle Cell Disease Treatment Revenue by Type (2018-2023) & (US$ Million)
    Table 14. Europe Sickle Cell Disease Treatment Revenue by Type (2024-2029) & (US$ Million)
    Table 15. Asia-Pacific Sickle Cell Disease Treatment Revenue by Type (2018-2023) & (US$ Million)
    Table 16. Asia-Pacific Sickle Cell Disease Treatment Revenue by Type (2024-2029) & (US$ Million)
    Table 17. Latin America Sickle Cell Disease Treatment Revenue by Type (2018-2023) & (US$ Million)
    Table 18. Latin America Sickle Cell Disease Treatment Revenue by Type (2024-2029) & (US$ Million)
    Table 19. Middle East and Africa Sickle Cell Disease Treatment Revenue by Type (2018-2023) & (US$ Million)
    Table 20. Middle East and Africa Sickle Cell Disease Treatment Revenue by Type (2024-2029) & (US$ Million)
    Table 21. Global Sickle Cell Disease Treatment Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
    Table 22. Global Sickle Cell Disease Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 23. Global Sickle Cell Disease Treatment Revenue Market Share by Application (2018-2023)
    Table 24. Global Sickle Cell Disease Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 25. Global Sickle Cell Disease Treatment Revenue Market Share by Application (2024-2029)
    Table 26. North America Sickle Cell Disease Treatment Revenue by Application (2018-2023) & (US$ Million)
    Table 27. North America Sickle Cell Disease Treatment Revenue by Application (2024-2029) & (US$ Million)
    Table 28. Europe Sickle Cell Disease Treatment Revenue by Application (2018-2023) & (US$ Million)
    Table 29. Europe Sickle Cell Disease Treatment Revenue by Application (2024-2029) & (US$ Million)
    Table 30. Asia-Pacific Sickle Cell Disease Treatment Revenue by Application (2018-2023) & (US$ Million)
    Table 31. Asia-Pacific Sickle Cell Disease Treatment Revenue by Application (2024-2029) & (US$ Million)
    Table 32. Latin America Sickle Cell Disease Treatment Revenue by Application (2018-2023) & (US$ Million)
    Table 33. Latin America Sickle Cell Disease Treatment Revenue by Application (2024-2029) & (US$ Million)
    Table 34. Middle East and Africa Sickle Cell Disease Treatment Revenue by Application (2018-2023) & (US$ Million)
    Table 35. Middle East and Africa Sickle Cell Disease Treatment Revenue by Application (2024-2029) & (US$ Million)
    Table 36. Global Sickle Cell Disease Treatment Revenue (US$ Million) by Players (2018-2023)
    Table 37. Global Sickle Cell Disease Treatment Revenue Market Share by Players (2018-2023)
    Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sickle Cell Disease Treatment as of 2022)
    Table 39. Date of Key Players Enter into Sickle Cell Disease Treatment Market
    Table 40. Global Sickle Cell Disease Treatment Key Players Headquarters and Area Served
    Table 41. Sickle Cell Disease Treatment Product Solution and Service
    Table 42. Global Sickle Cell Disease Treatment Players Market Concentration Ratio (CR5 and HHI)
    Table 43. Mergers & Acquisitions, Expansion Plans
    Table 44. AstraZeneca Basic Information List
    Table 45. AstraZeneca Description and Business Overview
    Table 46. AstraZeneca Sickle Cell Disease Treatment Products, Services and Solutions
    Table 47. Revenue (US$ Million) in Sickle Cell Disease Treatment Business of AstraZeneca (2018-2023)
    Table 48. AstraZeneca Recent Developments
    Table 49. Eli Lilly Basic Information List
    Table 50. Eli Lilly Description and Business Overview
    Table 51. Eli Lilly Sickle Cell Disease Treatment Products, Services and Solutions
    Table 52. Revenue (US$ Million) in Sickle Cell Disease Treatment Business of Eli Lilly (2018-2023)
    Table 53. Eli Lilly Recent Developments
    Table 54. Novartis Basic Information List
    Table 55. Novartis Description and Business Overview
    Table 56. Novartis Sickle Cell Disease Treatment Products, Services and Solutions
    Table 57. Revenue (US$ Million) in Sickle Cell Disease Treatment Business of Novartis (2018-2023)
    Table 58. Novartis Recent Developments
    Table 59. Pfizer Basic Information List
    Table 60. Pfizer Description and Business Overview
    Table 61. Pfizer Sickle Cell Disease Treatment Products, Services and Solutions
    Table 62. Revenue (US$ Million) in Sickle Cell Disease Treatment Business of Pfizer (2018-2023)
    Table 63. Pfizer Recent Developments
    Table 64. Baxter Basic Information List
    Table 65. Baxter Description and Business Overview
    Table 66. Baxter Sickle Cell Disease Treatment Products, Services and Solutions
    Table 67. Revenue (US$ Million) in Sickle Cell Disease Treatment Business of Baxter (2018-2023)
    Table 68. Baxter Recent Developments
    Table 69. Emmaus Life Sciences Basic Information List
    Table 70. Emmaus Life Sciences Description and Business Overview
    Table 71. Emmaus Life Sciences Sickle Cell Disease Treatment Products, Services and Solutions
    Table 72. Revenue (US$ Million) in Sickle Cell Disease Treatment Business of Emmaus Life Sciences (2018-2023)
    Table 73. Emmaus Life Sciences Recent Developments
    Table 74. Bluebird bio Basic Information List
    Table 75. Bluebird bio Description and Business Overview
    Table 76. Bluebird bio Sickle Cell Disease Treatment Products, Services and Solutions
    Table 77. Revenue (US$ Million) in Sickle Cell Disease Treatment Business of Bluebird bio (2018-2023)
    Table 78. Bluebird bio Recent Developments
    Table 79. Blood Therapeutics Basic Information List
    Table 80. Blood Therapeutics Description and Business Overview
    Table 81. Blood Therapeutics Sickle Cell Disease Treatment Products, Services and Solutions
    Table 82. Revenue (US$ Million) in Sickle Cell Disease Treatment Business of Blood Therapeutics (2018-2023)
    Table 83. Blood Therapeutics Recent Developments
    Table 84. Sangamo Therapeutics Basic Information List
    Table 85. Sangamo Therapeutics Description and Business Overview
    Table 86. Sangamo Therapeutics Sickle Cell Disease Treatment Products, Services and Solutions
    Table 87. Revenue (US$ Million) in Sickle Cell Disease Treatment Business of Sangamo Therapeutics (2018-2023)
    Table 88. Sangamo Therapeutics Recent Developments
    Table 89. Acceleron Pharma Basic Information List
    Table 90. Acceleron Pharma Description and Business Overview
    Table 91. Acceleron Pharma Sickle Cell Disease Treatment Products, Services and Solutions
    Table 92. Revenue (US$ Million) in Sickle Cell Disease Treatment Business of Acceleron Pharma (2018-2023)
    Table 93. Acceleron Pharma Recent Developments
    Table 94. Arena Pharmaceuticals Basic Information List
    Table 95. Arena Pharmaceuticals Description and Business Overview
    Table 96. Arena Pharmaceuticals Sickle Cell Disease Treatment Products, Services and Solutions
    Table 97. Revenue (US$ Million) in Sickle Cell Disease Treatment Business of Arena Pharmaceuticals (2018-2023)
    Table 98. Arena Pharmaceuticals Recent Developments
    Table 99. Alnylam Pharmaceuticals Basic Information List
    Table 100. Alnylam Pharmaceuticals Description and Business Overview
    Table 101. Alnylam Pharmaceuticals Sickle Cell Disease Treatment Products, Services and Solutions
    Table 102. Revenue (US$ Million) in Sickle Cell Disease Treatment Business of Alnylam Pharmaceuticals (2018-2023)
    Table 103. Alnylam Pharmaceuticals Recent Developments
    Table 104. Sanofi Basic Information List
    Table 105. Sanofi Description and Business Overview
    Table 106. Sanofi Sickle Cell Disease Treatment Products, Services and Solutions
    Table 107. Revenue (US$ Million) in Sickle Cell Disease Treatment Business of Sanofi (2018-2023)
    Table 108. Sanofi Recent Developments
    Table 109. CRISPR Therapeutics Basic Information List
    Table 110. CRISPR Therapeutics Description and Business Overview
    Table 111. CRISPR Therapeutics Sickle Cell Disease Treatment Products, Services and Solutions
    Table 112. Revenue (US$ Million) in Sickle Cell Disease Treatment Business of CRISPR Therapeutics (2018-2023)
    Table 113. CRISPR Therapeutics Recent Developments
    Table 114. Vertex Pharmaceuticals, Inc. Basic Information List
    Table 115. Vertex Pharmaceuticals, Inc. Description and Business Overview
    Table 116. Vertex Pharmaceuticals, Inc. Sickle Cell Disease Treatment Products, Services and Solutions
    Table 117. Revenue (US$ Million) in Sickle Cell Disease Treatment Business of Vertex Pharmaceuticals, Inc. (2018-2023)
    Table 118. Vertex Pharmaceuticals, Inc. Recent Developments
    Table 119. North America Sickle Cell Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 120. North America Sickle Cell Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 121. Europe Sickle Cell Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 122. Europe Sickle Cell Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 123. Asia-Pacific Sickle Cell Disease Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 124. Asia-Pacific Sickle Cell Disease Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 125. Asia-Pacific Sickle Cell Disease Treatment Market Size by Region (2024-2029) & (US$ Million)
    Table 126. Asia-Pacific Sickle Cell Disease Treatment Market Share by Region (2018-2023)
    Table 127. Asia-Pacific Sickle Cell Disease Treatment Market Share by Region (2024-2029)
    Table 128. Latin America Sickle Cell Disease Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 129. Latin America Sickle Cell Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 130. Latin America Sickle Cell Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 131. Middle East & Africa Sickle Cell Disease Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 132. Middle East & Africa Sickle Cell Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 133. Middle East & Africa Sickle Cell Disease Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 134. Sickle Cell Disease Treatment Market Trends
    Table 135. Sickle Cell Disease Treatment Market Drivers
    Table 136. Sickle Cell Disease Treatment Market Challenges
    Table 137. Sickle Cell Disease Treatment Market Restraints
    Table 138. Research Programs/Design for This Report
    Table 139. Key Data Information from Secondary Sources
    Table 140. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Sickle Cell Disease Treatment Market Size Year-over-Year 2018-2029 & (US$ Million)
    Figure 2. Global Sickle Cell Disease Treatment Market Size (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Sickle Cell Disease Treatment Market Share by Regions: 2022 VS 2029
    Figure 4. Global Sickle Cell Disease Treatment Forecasted Market Size Share by Region (2024-2029)
    Figure 5. North America Sickle Cell Disease Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 6. Europe Sickle Cell Disease Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 7. Asia-Pacific Sickle Cell Disease Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 8. Latin America Sickle Cell Disease Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 9. Middle East & Africa Sickle Cell Disease Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 10. Product Picture of Sickle Cell Anemia
    Figure 11. Global Sickle Cell Anemia Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 12. Product Picture of Sickle Beta Thalassemia
    Figure 13. Global Sickle Beta Thalassemia Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 14. Product Picture of Sickle Hemoglobin C Disease
    Figure 15. Global Sickle Hemoglobin C Disease Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 16. Global Sickle Cell Disease Treatment Market Size Share by Type: 2022 & 2029
    Figure 17. North America Sickle Cell Disease Treatment Revenue Market Share by Type (2018-2029)
    Figure 18. Europe Sickle Cell Disease Treatment Revenue Market Share by Type (2018-2029)
    Figure 19. Asia-Pacific Sickle Cell Disease Treatment Revenue Market Share by Type (2018-2029)
    Figure 20. Latin America Sickle Cell Disease Treatment Revenue Market Share by Type (2018-2029)
    Figure 21. Middle East and Africa Sickle Cell Disease Treatment Revenue Market Share by Type (2018-2029)
    Figure 22. Hospitals Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 23. Clinics Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 24. Others Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 25. Global Sickle Cell Disease Treatment Market Size Share by Application: 2022 & 2029
    Figure 26. North America Sickle Cell Disease Treatment Revenue Market Share by Application (2018-2029)
    Figure 27. Europe Sickle Cell Disease Treatment Revenue Market Share by Application (2018-2029)
    Figure 28. Asia-Pacific Sickle Cell Disease Treatment Revenue Market Share by Application (2018-2029)
    Figure 29. Latin America Sickle Cell Disease Treatment Revenue Market Share by Application (2018-2029)
    Figure 30. Middle East and Africa Sickle Cell Disease Treatment Revenue Market Share by Application (2018-2029)
    Figure 31. Sickle Cell Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 32. Global Top 5 and Top 10 Players Sickle Cell Disease Treatment Market Share in 2022
    Figure 33. North America Sickle Cell Disease Treatment Market Share by Country (2018-2029)
    Figure 34. United States Sickle Cell Disease Treatment Market Size (2018-2029) & (US$ Million)
    Figure 35. Canada Sickle Cell Disease Treatment Market Size (2018-2029) & (US$ Million)
    Figure 36. Germany Sickle Cell Disease Treatment Market Size (2018-2029) & (US$ Million)
    Figure 37. France Sickle Cell Disease Treatment Market Size (2018-2029) & (US$ Million)
    Figure 38. U.K. Sickle Cell Disease Treatment Market Size (2018-2029) & (US$ Million)
    Figure 39. Italy Sickle Cell Disease Treatment Market Size (2018-2029) & (US$ Million)
    Figure 40. Russia Sickle Cell Disease Treatment Market Size (2018-2029) & (US$ Million)
    Figure 41. Nordic Countries Sickle Cell Disease Treatment Market Size (2018-2029) & (US$ Million)
    Figure 42. Asia-Pacific Sickle Cell Disease Treatment Market Share by Region (2018-2029)
    Figure 43. China Sickle Cell Disease Treatment Market Size (2018-2029) & (US$ Million)
    Figure 44. Japan Sickle Cell Disease Treatment Market Size (2018-2029) & (US$ Million)
    Figure 45. South Korea Sickle Cell Disease Treatment Market Size (2018-2029) & (US$ Million)
    Figure 46. Southeast Asia Sickle Cell Disease Treatment Market Size (2018-2029) & (US$ Million)
    Figure 47. India Sickle Cell Disease Treatment Market Size (2018-2029) & (US$ Million)
    Figure 48. Australia Sickle Cell Disease Treatment Market Size (2018-2029) & (US$ Million)
    Figure 49. Latin America Sickle Cell Disease Treatment Market Share by Country (2018-2029)
    Figure 50. Mexico Sickle Cell Disease Treatment Market Size (2018-2029) & (US$ Million)
    Figure 51. Brazil Sickle Cell Disease Treatment Market Size (2018-2029) & (US$ Million)
    Figure 52. Middle East & Africa Sickle Cell Disease Treatment Market Share by Country (2018-2029)
    Figure 53. Turkey Sickle Cell Disease Treatment Market Size (2018-2029) & (US$ Million)
    Figure 54. Saudi Arabia Sickle Cell Disease Treatment Market Size (2018-2029) & (US$ Million)
    Figure 55. UAE Sickle Cell Disease Treatment Market Size (2018-2029) & (US$ Million)
    Figure 56. Bottom-up and Top-down Approaches for This Report
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3350

This license allows only one user to access the PDF.
Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-24R5886
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Congenital Heart Diseases Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-29D6035
Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Gardner Syndrome Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-28H13051
Tue Mar 26 00:00:00 UTC 2024

Add to Cart

Drugs for Alport Syndrome - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-16A13427
Tue Mar 26 00:00:00 UTC 2024

Add to Cart